Q3 2025 Outset Medical Inc Earnings Call Transcript
Key Points
- Outset Medical Inc (OM) reported an 8% increase in Tableau console sales in the third quarter, indicating growing demand for their technology.
- The company achieved a nearly 40% non-GAAP gross margin in the third quarter, showing progress towards their goal of a 50% gross margin.
- Outset Medical Inc (OM) has seen a significant increase in the average size of sales opportunities, growing by more than 20%, reflecting strong market interest.
- The company has a strong cash position with $182 million in cash equivalents, short-term investments, and restricted cash, providing a solid financial foundation.
- Clinical data presented at the Kidney Week conference demonstrated the effectiveness of their insourced dialysis solutions, supporting their market position and customer satisfaction.
- Outset Medical Inc (OM) experienced a shortfall in third-quarter results due to delays in closing large enterprise deals, impacting revenue expectations.
- The resignation of the head of sales may cause internal disruption and affect sales execution in the fourth quarter.
- The company revised its 2025 revenue guidance downward to a range of $115 to $120 million, from the previous $122 to $126 million.
- There were discrepancies in ordering patterns from large acute care customers, leading to mismatches between treatment utilization and revenue recognition.
- The transition in sales leadership could lead to fewer selling hours and potential distractions, impacting short-term sales performance.
Good day and thank you for standing by. Welcome to the Outset Medical Q3 2025 earnings conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question, please press 11 on your telephone. You will then hear an automated message advise your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I would now like to have my conference over to your speaker today, Jim Mazzola, head of investor relations. Please go ahead, sir.
Good afternoon everyone and welcome to our 3rd quarter 2025 earnings call. Here with me today as always, are Leslie Trigg, Chair and Chief Executive Officer, and Renee Gaeta, Chief Financial Officer. We issued a news release after the close of market today, which can be found on the investor pages of Outsetmedical.com. This call is being recorded and will be archived on the investor section of our website. It
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
